Details of the Drug

General Information of Drug (ID: DM44Z9R)

• Drug Name: BIIB 2024

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 2	[1]
Gastrointestinal stromal tumour	2B5B	Phase 2	[1]

• Cross-matching ID: TTD ID: D0J8BZ
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT00574236) Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer. U.S. National Institutes of Health.